See if PuraStat after Aquablation reduces bleeding and speeds discharge

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, single-blinded study evaluates the safety and potential benefits of using PuraStat hydrogel, applied with a syringe, after the Aquablation procedure for BPH. Researchers will grade post-operative bleeding 1–3 hours after surgery by photographing the urethral Foley catheter and comparing it to a standard scale. The trial also looks at whether PuraStat helps patients recover faster and increases the likelihood of same-day discharge, which is uncommon without the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Subject must be undergoing Aquablation
2. Subject is willing to comply with protocol requirements

Exclusion Criteria:

1. Any significant medical condition which, in the attending physician's opinion, may interfere with the patient's optimal procedure
2. Known or suspected systemic or severe infection
3. Patient unable to give consent

Where it's running

• Glenbrook Hospital- Endeavor Health
  Glenview, Illinois, United States Recruiting

Study contacts

• Study coordinator: Pooja Research Manager, MS MHA
• Email: PTalaty@northshore.org
• Phone: 847-503-34280

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Transurethral Thermodilatation vs Prostatic Urethral Lift for BPH in men 50–80

  This study tests whether Prolieve can match UroLift in relieving BPH symptoms in men 50–80 who haven’t had enough relief from medicines.

  Recruiting The University of Hong Kong · Hong Kong · NCT07759752

• Sonablate HIFU Registry for Prostate Cancer and BPH

  This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.

  Recruiting Sonablate · Indianapolis, Indiana · NCT07757490

• Beacon Platform for HoLEP: Safer, Smarter Prostate Surgery

  This trial tests whether the Beacon Platform can safely support the HoLEP procedure for men with enlarged prostates.

  Recruiting at 5 sites Andromeda Surgical · Sofia and 4 other locations · NCT07741656

• Veloxion disposable resectoscope system for BPH surgery

  This study tests whether the Veloxion disposable resectoscope helps perform endoscopic BPH surgery more efficiently and safely in men with moderate to large prostates.

  Recruiting Chinese University of Hong Kong · Shatin · NCT07728071

• Post-Exit Look at Reinterventions After ProVee Device Removal

  This study tests whether patients who left the ProVIDE studies and had a ProVee urethral expander removed go on to need secondary procedures for their LUTS.

  Recruiting ProVerum Medical · Lake Barrington, Illinois · NCT07680543

• Ultra-minimally invasive prostate balloon dilation for men with BPH and significant obstruction

  This study tests whether transrectal ultrasound–guided ultra-minimally invasive prostate balloon dilation can reduce urinary symptoms in men aged 40–80 with BPH and significant bladder outlet obstruction.

  Recruiting Chinese PLA General Hospital · Beijing · NCT07583706

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.